PolyPeptide Group

We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.

Media releases

Large-scale SPPS capacity in Braine-l’Alleud starts production

16 Dec 2024 - Baar, 16 December 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide-based active pharmaceutical ingredients, announces the start of production with the […]

Read more
Expert views

Peptide Manufacturing: Rethinking the Technology Platform for Large Scale Demand

13 Nov 2024 - Presented at TIDES Europe, November 13, 2024 Speaker: Jan Pawlas, Scientist Global Development Abstract: The peptide market is strongly impacted by the evolution of the development pipeline, […]

Read more
Business news

Vinnova grant awarded to joint project between PolyPeptide and Red Glead Discovery for developing a more sustainable manufacturing method for a GLP-1 agonist.

27 Aug 2024 - PolyPeptide in Limhamn, Sweden and Red Glead Discovery in Lund, Sweden have joined forces to pursue the development of a more sustainable manufacturing method for a […]

Read more
Ad hoc announcements pursuant to Art. 53 LR

Solid progress in H1 2024 – Upgrade of 2024 full-year guidance – Mid-term target to double 2023 revenue by 2028

13 Aug 2024 - Baar, 13 August 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide-based active pharmaceutical ingredients, today announced its results for H1 2024, […]

Read more
Expert views

Research article: Sustainable PFAS-free alternatives for TFA in SPPS

9 Aug 2024 - With growing manufacturing volumes, PolyPeptide remains dedicated to applying relevant principles of green chemistry. We are proud of our scientists pushing the frontiers and actively contributing […]

Read more
Media releases

PolyPeptide appoints Chief Commercial Officer

8 Aug 2024 - Baar, 8 August 2024 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligonucleotide-based active pharmaceutical ingredients, today announced the appointment of […]

Read more
Expert views

Advancing Sustainable Peptide Synthesis by Solvent Quality Control: Understanding and Mitigating Hydroperoxide in 1-Butyl-2-pyrrolidinone (NBP)

25 Jul 2024 - Org. Process Res. Dev. 2024, 28, 3347–3367 Pawlas, J.; Mohy El-Dine, T.; von Bargen, K.; von Bargen, C.; Nilsson, J.; Ludemann-Hombourger, O.; Rasmussen, J. H. See […]

Read more
Expert views

Trending topics at PolyPeptide

17 Jun 2024 - We are proud of our colleagues who regularly present at industry conferences to share their latest expert insights and experience in peptide manufacturing. Four of them […]

Read more
Media releases

PolyPeptide and Donaldson collaborate to develop solvent recovery system for peptide purification

13 May 2024 - MINNEAPOLIS / TORRANCE, Calif. May 13, 2024 – Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and […]

Read more